Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Anne Janeway, M.D.

Concepts (401)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Katherine Janeway's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Katherine Janeway has written about over time.
Succinate Dehydrogenase, 6 publications between 2009 and 2016, average publication date December 2012. Gastrointestinal Stromal Tumors, 16 publications between 2007 and 2021, average publication date June 2013. Receptor, Platelet-Derived Growth Factor alpha, 6 publications between 2007 and 2019, average publication date July 2013. Gastrointestinal Neoplasms, 8 publications between 2009 and 2021, average publication date May 2015. Clinical Trials, Phase II as Topic, 3 publications between 2014 and 2016, average publication date September 2015. Osteosarcoma, 39 publications between 2010 and 2024, average publication date December 2017. Bone Neoplasms, 48 publications between 2010 and 2024, average publication date September 2018. Protein-Tyrosine Kinases, 4 publications between 2009 and 2022, average publication date February 2019. Child, 103 publications between 2007 and 2024, average publication date March 2019. Fibromatosis, Aggressive, 3 publications between 2016 and 2020, average publication date June 2019. Molecular Targeted Therapy, 13 publications between 2016 and 2024, average publication date July 2019. Neoplasm Recurrence, Local, 21 publications between 2012 and 2023, average publication date July 2019. Sarcoma, 10 publications between 2012 and 2024, average publication date March 2020. High-Throughput Nucleotide Sequencing, 9 publications between 2016 and 2024, average publication date September 2020. Neoplasms, 30 publications between 2013 and 2024, average publication date November 2020. Neuroectodermal Tumors, Primitive, Peripheral, 4 publications between 2021 and 2023, average publication date May 2022.

To see the data from this visualization as text, click here.
Janeway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (401)
Explore
_
Co-Authors (163)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.